A large Swedish trial finds that AI-assisted mammography detects more breast cancers and reduces future diagnosis rates compared to standard practices.
Key Details
- 1MASAI trial included more than 105,000 women in Sweden between 2021-2022.
- 2AI-supported mammography led to a 12% reduction in subsequent breast cancer diagnoses.
- 3Trial compared AI triage/detection to the standard two-radiologist double reading.
- 4AI was developed/trained on over 200,000 exams from more than 10 countries.
- 5Implementation should be cautious, with monitoring and validated AI tools.
- 6Published in The Lancet; lead author is Dr. Kristina LÃ¥ng from Lund University.
Why It Matters
This is one of the first randomized controlled trials providing robust evidence that AI can enhance breast cancer screening programs, potentially improving early detection and reducing radiologist workload. These findings could accelerate responsible clinical adoption of AI in mammography.
Source
Radiology Business
Related News
•Radiology Business
NYC Health + Hospitals CEO Considers AI to Replace Radiologists
NYC Health + Hospitals CEO suggests AI could partially replace radiologists, pending regulatory approval.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.
•Radiology Business
Real-World Trial: AI Tool Cuts Radiologist Workload in Mammography
A prospective study shows AI can safely reduce radiologists’ workload and increase cancer detection in breast cancer screening.